Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio Independent of Comorbidity Burden in Melanoma

Supplementary Methods

Supplementary Tables
Mendeley Supplementary Table I. Clinicopathologic characteristics of the 288 enrolled patients (ALM versus NALM)
Mendeley Supplementary Table II. Univariable and multivariable Cox regression analyses for disease-free survival (279 patients)
Mendeley Supplementary Table III. Univariable and multivariable Cox regression analyses for distant-metastasis-free survival (279 patients)
Mendeley Supplementary Table IV. Clinicopathologic characteristics of the patients who received sentinel lymph node biopsy (225 patients)
Mendeley Supplementary Table V. Univariable and multivariable Cox regression analyses for melanoma-specific survival of negative SLN patients (171 patients)
Mendeley Supplementary Table VI. Univariable and multivariable Cox regression analyses for disease-free survival of negative SLN patients (171 patients)
Mendeley Supplementary Table VII. Univariable and multivariable Cox regression analyses for distant-metastasis-free survival of negative SLN patients (171 patients)

Supplementary Figures
Mendeley Supplementary Figure 1. Study participant flowchart.
Mendeley Supplementary Figure 2. Receiver operating characteristic curves.
Mendeley Supplementary Figure 3. Kaplan-Meier survival analysis for all included melanoma patients (288 patients).
Mendeley Supplementary Figure 4. Kaplan-Meier survival analysis for negative sentinel lymph node patients (171 patients).